Harmonization of Thyroid Stimulating Hormone; an Alternative Approach

Download Article

DOI: 10.21522/TIJAR.2014.03.02.Art003

Authors : Izza Abdulhafedh

Abstract:

Introduction: Comparison of TSH values by analysis of retrospective data obtained from daily internal quality control (IQC) runs performed concurrently on Architect i2000 and cobas e601; the two platforms used to run TSH test for patient samples at The Nairobi Hospital, Kenya.

Method: Data analysis was carried out using R project version 3.2.3. Data was analyzed both in combination (N=590) and segregated as Level 2 (N= 297) and level 3 (N=293).  

Results: Shapiro-Wilk normality test returned normal distribution for level 2, abnormal distribution for level 3 and combined data on both platforms. Paired T-test for level 2 and Mann–Whitney U -Wilcoxon signed rank test for level 3 and combined data, indicated that the alternative hypothesis: true location shift is not equal to 0. Deming and Passing-Bablok regression analysis for level 2 and 3 showed a significant deviation in values between the two methods by a constant. Concordance correlation of the individual levels 2 and 3 is poor.

Discussion: The data demonstrates that there is a constant systematic error between the two methods, with cobas values reading higher each time, and that this difference is significant at both levels.

Conclusion: Regression analysis shows transferability of results from one method to another, however, the difference in means and the poor concordance correlation obliges a consideration of the TSH value results given by the lab especially so in the subclinical range (5 – 10) mIU/ml.

Keywords: Thyroid Stimulating Hormone, TSH, Architect i2000SR, Cobas e601

References:

[1]. BALOCH, Z., CARAYON, P., CONTE-DEVOLX, B., DEMERS, L. M., FELDT-RASMUSSEN, U., HENRY, J. F., LIVOSLI, V. A., NICCOLI-SIRE, P., JOHN, R., RUF, J., SMYTH, P. P., SPENCER, C. A. & STOCKIGT, J. R. 2003. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid, 13, 3-126.

[2]. BENDIX CARSTENSEN, L. G., CLAUS EKSTROM AND MICHAL FIGURSKI 2015. MethComp: Functions for Analysis of Agreement in Method Comparison Studies. R package version 1.22.2.

[3]. FAIX, J. D., AND THIENPONT, LINDA M 2013. Thyroid-Stimulating Hormone; Why Efforts to Harmonize Testing Are Critical to Patient Care. Clinical Laboratory News.

[4]. HENDRIKS, H. A., KORTLANDT, W. & VERWEIJ, W. M. 2000. Standardized comparison of processing capacity and efficiency of five new-generation immunoassay analyzers. Clin Chem, 46, 105-11.

[5]. JENSEN, A. L. & KJELGAARD-HANSEN, M. 2006. Method comparison in the clinical laboratory. Veterinary Clinical Pathology, 35, 276-286.

[6]. LAWRENCE, I. & LIN, K. 1989. A concordance correlation coefficient to evaluate reproducibility. Biometrics, 255-268.

[7]. LIN, Y. Y. A. L. 2011. Statistical Tools for Measuring Agreement. 0.8-1 ed.

[8]. (NIDDK), N. I. O. D. A. D. A. K. D. 2014. Thyroid Tests [Online]. NIH Publication No. 14–6284. Available: http://www.endocrine.niddk.nih.gov/ [Accessed January 1st 2016].

[9]. ODELL, W. D., WILBER, J. F. & PAUL, W. E. 1965. Radioimmunoassay of thyrotropin in human serum. The Journal of Clinical Endocrinology & Metabolism, 25, 1179-1188.

[10]. R CORE TEAM 2015. R: A language and environment for statistical computing 3.2.3 ed. Vienna, Austria: The R Foundation for Statistical Computing.

[11]. SARKAR, R. 2014. TSH Comparison Between Chemiluminescence (Architect) and Electrochemiluminescence (Cobas) Immunoassays: An Indian Population Perspective. Indian Journal of Clinical Biochemistry, 29, 189-195.

[12]. SERDAR, M. A., İSPIR, E., OZGURTAS, T., GULBAHAR, O., CIRACI, Z., PASAOGLU, H. & KURT, I. 2015. Comparison of four immunoassay analyzers for relationship between thyroid stimulating hormone (TSH) and free thyroxine (FT4)/[Dört immünolojik ölçüm cihazının tiroid stimüle edici hormon (TSH) ve serbest tiroksin (FT4) arasındaki ilişki yönünden karşılaştırılması]. Turkish Journal of Biochemistry, 40, 88-91.

[13]. SPENCER, C. A. 2013. Assay of thyroid hormones and related substances. In: DE GROOT LJ, C. G., DUNGAN K, ET AL., EDITORS: ENDOTEXT [INTERNET]. (ed.). South Dartmouth (MA): MDText.com, Inc.; 2000.

[14]. SURKS, M. I., ORTIZ, E., DANIELS, G. H. & ET AL. 2004. Subclinical thyroid disease: Scientific review and guidelines for diagnosis and management. JAMA, 291, 228-238.

[15]. UTIGER, R. D. 1965. Radioimmunoassay of human plasma thyrotropin. Journal of Clinical Investigation, 44, 1277.

[16]. WESTGARD, J. O., BARRY, P. L., QUAM, E. F. & EHRMEYER, S. S. 1999. Basic method validation: training in analytical quality management for healthcare laboratories, Westgard Quality Corporation.

[17]. WILLIAMS, D. P. 2015. 1400 Update of Status of standardisation of TFTs Royal Prince Alfred Hospital and University of Sydney.

[18]. YALOW, R. S. & BERSON, S. A. 1996. Immunoassay of endogenous plasma insulin in man. Obesity research, 4, 583-600.

[19]. YAU, C. 2009-2016. R Tutorial An Introduction to R Statistics. r-Tutor.com.